| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 6 Feb 25 | RVNC Revance Therapeutics | Common Stock | Sale back to company | Dispose D | No | No | 0 | 20,883 | 0.00 | 0 |
| 6 Feb 25 | RVNC Revance Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 20,883 | 0.00 | 20,883 |
| 6 Feb 25 | RVNC Revance Therapeutics | Common Stock | Sale back to company | Dispose D | No | No | 0 | 103,555 | 0.00 | 0 |
| 4 Feb 25 | RVNC Revance Therapeutics | Common Stock | Dispose U | No | No | 3.65 | 97,999 | 357.70 k | 103,555 | |
| 3 Feb 25 | RVNC Revance Therapeutics | Common Stock | Grant | Acquire A | No | No | 0 | 6,888 | 0.00 | 201,554 |
| 31 Dec 24 | RVNC Revance Therapeutics | Common Stock | Grant | Acquire A | No | No | 2.1845 | 1,000 | 2.18 k | 194,666 |
| 30 Jun 24 | RVNC Revance Therapeutics | Common Stock | Grant | Acquire A | No | No | 2.1845 | 1,000 | 2.18 k | 193,666 |
